#LCSM Chat Topic 5/3/18:  What Defines a “Quality” #LungCancer Treatment Center?  Thoughts from the Frontline

Our topic for the #LCSM Tweet Chat on Thursday, May 3rd (5 PM Pacific/8 PM Eastern) is “What Defines a “Quality” #LungCancer Treatment Center?  Thoughts from the Frontline.” The moderator for this chat is Dr. David Tom Cooke (@DavidCookeMD). Recently the Centers for Medicaid and Medicare Services (CMS) announced it would cover next-generation sequencing (NGS) for US patients with stage III or IV lung cancer when ordered by a physician and performed in a CLIA-certified laboratory.  This decision makes broad genomic testing to available to many more patients.  Having increased access to… Read More

#LCSM Chat Topic 2/8/18: Right to Try Laws and CIMAVax

  “Right to Try” laws for people with a terminal illness have been a longstanding issue and are currently on the books in 38 states. The lack of a federal law supporting this concept was touched upon in President Trump’s State of the Union address last week. On its face, offering liberal options that permit these patients to try any still investigational agent that has completed phase I testing seems like a benefit to patients who may be desperate for options. A couple of arguments in favor of it are available here:… Read More

#LCSM Chat Topic 10/19: World Conference on Lung Cancer (#WCLC2017) Wrap-Up

Please join the #LCSM community and moderator Brendon Stiles  (@BrendonStilesMD) for the next #LCSM Chat on Thursday, October 19th, at 8 pm Eastern Time (5 pm Pacific).  The topic of the chat will be “World Conference on Lung Cancer 2017 Wrap-Up.” The annual World Conference on Lung Cancer, known on Twitter this year as #WCLC2017, is the world’s largest meeting dedicated to lung cancer.  Hosted by the International Association for the Study of Lung Cancer (@IASLC), the conference is taking place from October 15-18th in Yokohama, Japan.  The conference’s motto, “Synergy to… Read More